Oryzon Genomics S.A. - 0RDB.L - Fundamentals

Best investment/trading ideas for the weekJoin our free webinar on April8,2026.

Combo Screeneris now available. Explore seasonality and pattern opportunities across asset classes.

Explore now

‌
‌

‌

Let's get started...

‌

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	0	0	0	14	7	0	--	📊
Revenue Growth (1Y)	--	--	--	--	--	-48.15%	-100.00%	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	0	-9	-10	-15	0	0	0	--	📊
Cost of Revenue Growth (1Y)	--	--	-9.73%	-54.36%	+101.60%	+24.00%	-55.69%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	+103.36%	+101.36%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	0	9	10	15	14	7	-0	--	📊
Gross Profit Growth (1Y)	--	--	+9.73%	+54.36%	-8.44%	-49.41%	-101.90%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	--	-21.55%	-101.36%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	11	13	17	21	18	11	6	10	📊
Operating Expenses Growth (1Y)	--	+25.93%	+27.04%	+22.80%	-10.75%	-37.94%	-45.25%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+75.34%	-13.59%	-62.76%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	11	10	13	18	4	3	-6	--	📊
Research and Development	0	0	0	0	6	0	13	11	📊
Other Income Expenses	-0	0	0	0	9	8	0	-1	📊
EBITDA	-4	-4	-7	-5	-4	-4	-6	-5	📊
EBITDA Growth (1Y)	--	-12.55%	-65.38%	+22.23%	+17.14%	-0.01%	-41.75%	--	📊
EBITDA Growth (5Y)	--	--	--	--	-19.95%	-6.58%	+8.65%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	0	0	0	0	0	0	--	📊
Operating Income	-11	-4	-7	-5	-5	-4	-6	-6	📊
Operating Income Growth (1Y)	--	+59.29%	-63.26%	+21.69%	+17.14%	+2.77%	-45.13%	--	📊
Operating Income Growth (5Y)	--	--	--	--	+56.88%	-3.00%	+8.44%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	1	2	0	1	--	📊
Pre Tax Income	0	-5	-7	-7	-6	-6	-6	-6	📊
Tax Provision	0	-1	-2	-2	-3	2	-3	-3	📊
NET INCOME	0	-3	-5	-4	-3	-4	-3	-3	📊
Net Income Growth (1Y)	--	--	-37.87%	+9.72%	+20.76%	-9.32%	+28.92%	--	📊
Net Income Growth (5Y)	--	--	--	--	--	-7.82%	+44.41%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	0	-0.06	-0.09	-0.08	-0.06	-0.06	-0.04	-0.04	📊
Diluted EPS	0	-0.06	-0.09	-0.08	-0.06	-0.06	-0.04	-0.04	📊
Basic Average Shares	53	53	53	56	61	64	74	54	📊
Diluted Average Shares	53	53	53	56	61	64	74	54	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

-48.15%

-100.00%

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

-9

-10

-15

📊

Cost of Revenue Growth (1Y)

-9.73%

-54.36%

+101.60%

+24.00%

-55.69%

📊

Cost of Revenue Growth (5Y)

+103.36%

+101.36%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-0

📊

Gross Profit Growth (1Y)

+9.73%

+54.36%

-8.44%

-49.41%

-101.90%

📊

Gross Profit Growth (5Y)

-21.55%

-101.36%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+25.93%

+27.04%

+22.80%

-10.75%

-37.94%

-45.25%

📊

Operating Expenses Growth (5Y)

+75.34%

-13.59%

-62.76%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

-6

📊

Research and Development

📊

Other Income Expenses

-0

-1

📊

EBITDA

-4

-7

-5

-4

-6

-5

📊

EBITDA Growth (1Y)

-12.55%

-65.38%

+22.23%

+17.14%

-0.01%

-41.75%

📊

EBITDA Growth (5Y)

-19.95%

-6.58%

+8.65%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-11

-4

-7

-5

-4

-6

📊

Operating Income Growth (1Y)

+59.29%

-63.26%

+21.69%

+17.14%

+2.77%

-45.13%

📊

Operating Income Growth (5Y)

+56.88%

-3.00%

+8.44%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-5

-7

-6

📊

Tax Provision

-1

-2

-3

📊

NET INCOME

-3

-5

-4

-3

-4

-3

📊

Net Income Growth (1Y)

-37.87%

+9.72%

+20.76%

-9.32%

+28.92%

📊

Net Income Growth (5Y)

-7.82%

+44.41%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.06

-0.09

-0.08

-0.06

-0.04

📊

Diluted EPS

-0.06

-0.09

-0.08

-0.06

-0.04

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	0	0	0	14	7	0	--	📊
Revenue Growth (1Y)	--	--	--	--	--	-48.15%	-100.00%	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	0	-9	-10	-15	0	0	0	--	📊
Cost of Revenue Growth (1Y)	--	--	-9.73%	-54.36%	+101.60%	+24.00%	-55.69%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	+103.36%	+101.36%	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	0	9	10	15	14	7	-0	--	📊
Gross Profit Growth (1Y)	--	--	+9.73%	+54.36%	-8.44%	-49.41%	-101.90%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	--	-21.55%	-101.36%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	11	13	17	21	18	11	6	10	📊
Operating Expenses Growth (1Y)	--	+25.93%	+27.04%	+22.80%	-10.75%	-37.94%	-45.25%	--	📊
Operating Expenses Growth (5Y)	--	--	--	--	+75.34%	-13.59%	-62.76%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	11	10	13	18	4	3	-6	--	📊
Research and Development	0	0	0	0	6	0	13	11	📊
Other Income Expenses	-0	0	0	0	9	8	0	-1	📊
EBITDA	-4	-4	-7	-5	-4	-4	-6	-5	📊
EBITDA Growth (1Y)	--	-12.55%	-65.38%	+22.23%	+17.14%	-0.01%	-41.75%	--	📊
EBITDA Growth (5Y)	--	--	--	--	-19.95%	-6.58%	+8.65%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	0	0	0	0	0	0	--	📊
Operating Income	-11	-4	-7	-5	-5	-4	-6	-6	📊
Operating Income Growth (1Y)	--	+59.29%	-63.26%	+21.69%	+17.14%	+2.77%	-45.13%	--	📊
Operating Income Growth (5Y)	--	--	--	--	+56.88%	-3.00%	+8.44%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	1	2	0	1	--	📊
Pre Tax Income	0	-5	-7	-7	-6	-6	-6	-6	📊
Tax Provision	0	-1	-2	-2	-3	2	-3	-3	📊
NET INCOME	0	-3	-5	-4	-3	-4	-3	-3	📊
Net Income Growth (1Y)	--	--	-37.87%	+9.72%	+20.76%	-9.32%	+28.92%	--	📊
Net Income Growth (5Y)	--	--	--	--	--	-7.82%	+44.41%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	0	-0.06	-0.09	-0.08	-0.06	-0.06	-0.04	-0.04	📊
Diluted EPS	0	-0.06	-0.09	-0.08	-0.06	-0.06	-0.04	-0.04	📊
Basic Average Shares	53	53	53	56	61	64	74	54	📊
Diluted Average Shares	53	53	53	56	61	64	74	54	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

-48.15%

-100.00%

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

-9

-10

-15

📊

Cost of Revenue Growth (1Y)

-9.73%

-54.36%

+101.60%

+24.00%

-55.69%

📊

Cost of Revenue Growth (5Y)

+103.36%

+101.36%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-0

📊

Gross Profit Growth (1Y)

+9.73%

+54.36%

-8.44%

-49.41%

-101.90%

📊

Gross Profit Growth (5Y)

-21.55%

-101.36%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+25.93%

+27.04%

+22.80%

-10.75%

-37.94%

-45.25%

📊

Operating Expenses Growth (5Y)

+75.34%

-13.59%

-62.76%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

-6

📊

Research and Development

📊

Other Income Expenses

-0

-1

📊

EBITDA

-4

-7

-5

-4

-6

-5

📊

EBITDA Growth (1Y)

-12.55%

-65.38%

+22.23%

+17.14%

-0.01%

-41.75%

📊

EBITDA Growth (5Y)

-19.95%

-6.58%

+8.65%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-11

-4

-7

-5

-4

-6

📊

Operating Income Growth (1Y)

+59.29%

-63.26%

+21.69%

+17.14%

+2.77%

-45.13%

📊

Operating Income Growth (5Y)

+56.88%

-3.00%

+8.44%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-5

-7

-6

📊

Tax Provision

-1

-2

-3

📊

NET INCOME

-3

-5

-4

-3

-4

-3

📊

Net Income Growth (1Y)

-37.87%

+9.72%

+20.76%

-9.32%

+28.92%

📊

Net Income Growth (5Y)

-7.82%

+44.41%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.06

-0.09

-0.08

-0.06

-0.04

📊

Diluted EPS

-0.06

-0.09

-0.08

-0.06

-0.04

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-10.54%
Next Earnings	--
Market cap	2.19M (EUR)
EPS (TTM)	-0.04 (€)
P/E (TTM)	-69.75 (€)
Last Close	2.82

Next Earnings	--
Market cap	2.19M (EUR)
EPS (TTM)	-0.04 (€)
P/E (TTM)	-69.75 (€)
Last Close	2.82 (€)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-10.54%
Next Earnings	--
Market cap	2.19M (EUR)
EPS (TTM)	-0.04 (€)
P/E (TTM)	-69.75 (€)
Last Close	2.82

Next Earnings	--
Market cap	2.19M (EUR)
EPS (TTM)	-0.04 (€)
P/E (TTM)	-69.75 (€)
Last Close	2.82 (€)